AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: breast cancer riskClear filter
industrykoreabiomed.com

Lunit’s U.S. Breast Cancer Push Shows How Guideline Changes Can Reopen Markets for AI

Korean AI imaging company Lunit is reportedly targeting the U.S. breast cancer risk market after an NCCN guideline update. The move shows how fast-moving clinical guidelines can reshape commercial opportunities for AI vendors. For AI companies, the policy environment is not just a backdrop — it is often the main gatekeeper to adoption.

AIbreast cancer riskNCCNguidelines

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.